Jin Li, Wang Wensu, Zhang Rong, Shen Jianguo, Li Yangyang, Zhang Yi
Department of Endocrinology and Metabolism, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Department of Geriatrics, The Second Affiliated Hospital of Guizhou University of TCM, Guizhou, Guiyang, China.
Ther Adv Chronic Dis. 2024 Oct 16;15:20406223241286677. doi: 10.1177/20406223241286677. eCollection 2024.
Diabetic kidney disease (DKD) is a severe complication of diabetes mellitus and is associated with an increased risk of end-stage renal disease (ESRD) and cardiovascular events. Early diagnosis and monitoring of DKD are crucial for implementing appropriate interventions. This study aimed to investigate the relationship between serum renalase (RNLS) levels, DKD, and diabetic macroangiopathy in patients with type 2 diabetes mellitus (T2DM).
This study aims to evaluate the diagnostic value of serum renalase levels in DKD and diabetic macroangiopathy.
This is a retrospective case-control study.
A total of 233 participants were recruited for the study, including 115 T2DM patients without DKD or diabetic retinopathy, and 118 T2DM patients with DKD. Serum RNLS levels were measured using an enzyme-linked immunosorbent assay. Kidney function parameters and diabetic macroangiopathy risk factors were evaluated in relation to serum RNLS levels.
Serum RNLS levels were significantly higher in DKD patients compared to T2DM controls (34.82 (31.68, 39.37) vs 30.52 (28.58, 33.16), < 0.01). Multiple linear regression analysis indicated that kidney function parameters and carotid intima-media thickness were independently related to RNLS levels. The study population was divided into four groups: no DKD and no diabetic macroangiopathy, DKD without diabetic macroangiopathy, diabetic macroangiopathy without DKD, and both DKD and diabetic macroangiopathy. Analysis results showed that patients with both DKD and diabetic macroangiopathy had the highest RNLS levels. Receiver operating characteristic curve analysis demonstrated the diagnostic value of RNLS for DKD (0.76 (95% confidence interval (CI) = 0.70-0.82, < 0.01)) and diabetic macroangiopathy (0.75 (95% CI = 0.66-0.84, < 0.01)).
Circulating RNLS levels were significantly increased in patients with DKD and diabetic macroangiopathy, suggesting that RNLS may serve as an early diagnostic marker.
糖尿病肾病(DKD)是糖尿病的一种严重并发症,与终末期肾病(ESRD)和心血管事件风险增加相关。DKD的早期诊断和监测对于实施适当干预至关重要。本研究旨在探讨2型糖尿病(T2DM)患者血清肾酶(RNLS)水平、DKD和糖尿病大血管病变之间的关系。
本研究旨在评估血清肾酶水平在DKD和糖尿病大血管病变中的诊断价值。
这是一项回顾性病例对照研究。
共招募233名参与者进行研究,包括115例无DKD或糖尿病视网膜病变的T2DM患者,以及118例患有DKD的T2DM患者。采用酶联免疫吸附测定法测量血清RNLS水平。评估肾功能参数和糖尿病大血管病变危险因素与血清RNLS水平的关系。
与T2DM对照组相比,DKD患者的血清RNLS水平显著更高(34.82(31.68,39.37)对30.52(28.58,33.16),<0.01)。多元线性回归分析表明,肾功能参数和颈动脉内膜中层厚度与RNLS水平独立相关。研究人群分为四组:无DKD且无糖尿病大血管病变、有DKD但无糖尿病大血管病变、有糖尿病大血管病变但无DKD、既有DKD又有糖尿病大血管病变。分析结果显示,既有DKD又有糖尿病大血管病变的患者RNLS水平最高。受试者工作特征曲线分析证明了RNLS对DKD(0.76(95%置信区间(CI)=0.70-0.82,<0.01))和糖尿病大血管病变(0.75(95%CI=0.66-0.84,<0.01))的诊断价值。
DKD和糖尿病大血管病变患者的循环RNLS水平显著升高,提示RNLS可能作为一种早期诊断标志物。